|
Literature for OMIM 273395: TETRAAMELIA SYNDROME 1; TETAMS1
Xenbase Articles:
(
Denotes literature images)
The Wnt-dependent signaling pathways as target in oncology drug discovery.,
Janssens N,Janicot M,Perera T,
Invest New Drugs. July 1, 2006; 24(4):0167-6997.
|
RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6.,
Szenker-Ravi E,Altunoglu U,Leushacke M,Khatoo M,Thi Tran H,Naert T,Noelanders R,Beneteau C,de Sousa SB,Karaman B,Başaran S,Tan TT,Vlaminck L,Nayak SS,Girisha KM,Le Caignec C,Soshnikova N,Vleminckx K,Vleminckx K,Barker N,Kayserili H,Bosso-Lefèvre C,Hajamohideen A,Latypova X,Yücel EB,Shukla A,Uyguner ZO,Reversade B,
Nature. May 1, 2018; 557(7706):0143-5221.
|
Wnt/beta-catenin signaling: components, mechanisms, and diseases.,
MacDonald BT,Tamai K,He X,
Dev Cell. July 1, 2009; 17(1):1878-1551.
|
